Exelixis Collaboration Agreements

63 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Fifth Amendment to Collaboration and License Agreement between Exelixis, Inc. and Ipsen Pharma SAS
Collaboration Agreements
Exelixis
Biotechnology
2023
Fourth Amendment to Collaboration and License Agreement between Exelixis, Inc. and Ipsen Pharma SAS
Collaboration Agreements
Exelixis
Biotechnology
2023
Second Amendment to Collaboration and License Agreement between Exelixis, Inc. and Takeda Pharmaceutical Company Limited
Collaboration Agreements
Exelixis
Biotechnology
2022
Third Amendment to Collaboration and License Agreement between Exelixis, Inc. and Ipsen Pharma SAS
Collaboration Agreements
Exelixis
Biotechnology
2021
Second Amendment to Collaboration and License Agreement between Exelixis, Inc. and Ipsen Pharma SAS
Collaboration Agreements
Exelixis
Biotechnology
2021
First Amendment to Collaboration and License Agreement between Exelixis, Inc. and Ipsen Pharma SAS
Collaboration Agreements
Exelixis
Biotechnology
2021
Third Amendment to Collaboration and License Agreement between Exelixis, Inc. and Takeda Pharmaceutical Company Limited
Collaboration Agreements
Exelixis
Biotechnology
2020
Amendment No. 2 to the Ipsen Supplement Agreement among Exelixis, Inc., Bristol-Myers Squibb Company, and Ipsen Pharma SAS
Collaboration Agreements
Exelixis
Biotechnology
2020
Supplement to Joint Clinical Research Agreement among Exelixis, Roche, and Ipsen (December 18, 2019)
Collaboration Agreements
Exelixis
Biotechnology
CA
2020
Joint Clinical Research Agreement between Exelixis, Inc. and F. Hoffmann-La Roche Ltd (December 18, 2019)
Collaboration Agreements
Exelixis
Biotechnology
CA
2020
Second Amendment to Collaboration and License Agreement between Exelixis, Inc. and Takeda Pharmaceutical Company Limited
Collaboration Agreements
Exelixis
Biotechnology
2019
Amendment No. 3 to Cooperative Research and Development Agreement Between Exelixis Inc. and National Cancer Institute for Cabozantinib Clinical Development
Collaboration Agreements
Exelixis
Biotechnology
2019
Ono Territory Supplemental Agreement among Ono Pharmaceutical, Bristol-Myers Squibb, and Exelixis (July 6, 2018)
Collaboration Agreements
Exelixis
Biotechnology
NY
2018
Supplement to Clinical Trial Collaboration Agreement among Exelixis, Inc., Bristol-Myers Squibb Company, and Takeda Pharmaceutical Company Limited
Collaboration Agreements
Exelixis
Biotechnology
NY
2018
Amendment to Ipsen Supplement Agreement to Clinical Trial Collaboration Agreement among Exelixis, Inc., Bristol-Myers Squibb Company, and Ipsen Pharma SAS
Collaboration Agreements
Exelixis
Biotechnology
2018
First Amendment to Collaboration and License Agreement between Exelixis, Inc. and Takeda Pharmaceutical Company Limited
Collaboration Agreements
Exelixis
Biotechnology
2018
Third Amendment to Collaboration and License Agreement between Exelixis, Inc. and Ipsen Pharma SAS
Collaboration Agreements
Exelixis
Biotechnology
2018
Second Amendment to Collaboration and License Agreement between Exelixis, Inc. and Ipsen Pharma SAS
Collaboration Agreements
Exelixis
Biotechnology
2017
Third Amendment to Collaboration Agreement between Exelixis, Inc. and Genentech, Inc.
Collaboration Agreements
Exelixis
Biotechnology
2017
Supplement to Clinical Trial Collaboration Agreement among Exelixis, Bristol-Myers Squibb, and Ipsen Pharma SAS (February 24, 2017)
Collaboration Agreements
Exelixis
Biotechnology
NY
2017
Clinical Trial Collaboration Agreement between Exelixis, Inc. and Bristol-Myers Squibb Company
Collaboration Agreements
Exelixis
Biotechnology
NY
2017
First Amendment to Collaboration Agreement between Exelixis, Inc. and Genentech, Inc.
Collaboration Agreements
Exelixis
Biotechnology
2017
Collaboration Agreement between Exelixis, Inc. and Genentech, Inc. (December 22, 2006)
Collaboration Agreements
Exelixis
Biotechnology
CA
2017
First Amendment to Collaboration and License Agreement between Exelixis, Inc. and Ipsen Pharma SAS
Collaboration Agreements
Exelixis
Biotechnology
2017
Amendment No. 2 to Cooperative Research and Development Agreement Between Exelixis Inc. and National Cancer Institute
Collaboration Agreements
Exelixis
Biotechnology
2017
Amendment No. 1 to Cooperative Research and Development Agreement (CRADA) between Exelixis Inc. and National Cancer Institute for Cabozantinib Clinical Development
Collaboration Agreements
Exelixis
Biotechnology
2017
Cooperative Research and Development Agreement for Clinical Research between National Cancer Institute and Exelixis, Inc.
Collaboration Agreements
Exelixis
Biotechnology
DC
2017
Amended and Restated Collaboration Agreement between Exelixis, Inc., Exelixis Patent Company, LLC, and Bristol-Myers Squibb Company
Collaboration Agreements
Exelixis
Biotechnology
DE
2016
Collaboration Agreement between Exelixis, Inc. and Sanofi-Aventis dated May 27, 2009
Collaboration Agreements
Exelixis
Biotechnology
NY
2014
Product Development and Commercialization Agreement between SmithKline Beecham Corporation (GlaxoSmithKline) and Exelixis, Inc. dated October 28, 2002
Collaboration Agreements
Exelixis
Biotechnology
NY
2013
Amended and Restated Collaboration Agreement between Exelixis, Inc., Exelixis Patent Company, LLC, and Bristol-Myers Squibb Company
Collaboration Agreements
Exelixis
Biotechnology
DE
2011
Amended and Restated Collaboration Agreement between Exelixis, Inc., Exelixis Patent Company, LLC, and Bristol-Myers Squibb Company
Collaboration Agreements
Exelixis
Biotechnology
DE
2011
Amended and Restated Collaboration Agreement between Exelixis, Inc., Exelixis Patent Company, LLC, and Bristol-Myers Squibb Company
Collaboration Agreements
Exelixis
Biotechnology
DE
2011
Collaboration Agreement between Exelixis, Inc. and Bristol-Myers Squibb Company (October 8, 2010)
Collaboration Agreements
Exelixis
Biotechnology
DE
2011
Amendment No. 3 to Collaboration Agreement between Exelixis, Inc. and Bristol-Myers Squibb Company (October 8, 2010)
Collaboration Agreements
Exelixis
Biotechnology
2011
Amendment No. 3 to Collaboration Agreement between Exelixis, Inc. and Bristol-Myers Squibb Company (October 8, 2010)
Collaboration Agreements
Exelixis
Biotechnology
2011
Second Amendment to Collaboration Agreement between Exelixis, Inc. and Genentech, Inc. (Effective April 30, 2010)
Collaboration Agreements
Exelixis
Biotechnology
2010
Fifth Amendment to Contract Research Agreement between Agrigenetics, Inc. and Exelixis Plant Sciences, Inc.
Collaboration Agreements
Exelixis
Biotechnology
DE
2009
Amendment No. 2 to Collaboration Agreement between Exelixis, Inc. and Bristol-Myers Squibb Company (Effective October 1, 2009)
Collaboration Agreements
Exelixis
Biotechnology
2009
Amendment No. 2 to Collaboration Agreement between Exelixis, Inc. and Bristol-Myers Squibb Company (Effective September 1, 2009)
Collaboration Agreements
Exelixis
Biotechnology
2009